Pantazis, N.; Papastamopoulos, V.; Antoniadou, A.; Adamis, G.; Paparizos, V.; Metallidis, S.; Sambatakou, H.; Psichogiou, M.; Chini, M.; Chrysos, G.;
et al. Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug. Viruses 2022, 14, 1677.
https://doi.org/10.3390/v14081677
AMA Style
Pantazis N, Papastamopoulos V, Antoniadou A, Adamis G, Paparizos V, Metallidis S, Sambatakou H, Psichogiou M, Chini M, Chrysos G,
et al. Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug. Viruses. 2022; 14(8):1677.
https://doi.org/10.3390/v14081677
Chicago/Turabian Style
Pantazis, Nikos, Vasilios Papastamopoulos, Anastasia Antoniadou, Georgios Adamis, Vasilios Paparizos, Simeon Metallidis, Helen Sambatakou, Mina Psichogiou, Maria Chini, Georgios Chrysos,
and et al. 2022. "Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug" Viruses 14, no. 8: 1677.
https://doi.org/10.3390/v14081677
APA Style
Pantazis, N., Papastamopoulos, V., Antoniadou, A., Adamis, G., Paparizos, V., Metallidis, S., Sambatakou, H., Psichogiou, M., Chini, M., Chrysos, G., Panagopoulos, P., Sipsas, N. V., Barbunakis, E., Gogos, C., & Touloumi, G., on behalf of the Athens Multicenter AIDS Cohort Study (AMACS).
(2022). Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug. Viruses, 14(8), 1677.
https://doi.org/10.3390/v14081677
